Cardlytics
CDLX
204 hedge funds and large institutions have $3.35B invested in Cardlytics in 2021 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 68 increasing their positions, 66 reducing their positions, and 36 closing their positions.
31% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 36
5% more funds holding
Funds holding: 195 → 204 (+9)
3% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 66
2% more call options, than puts
Call options by funds: $10.9M | Put options by funds: $10.7M
0.57% less ownership
Funds ownership: 10.2% → 9.63% (-0.57%)
16% less capital invested
Capital invested by funds: $3.97B → $3.35B (-$618M)
21% less funds holding in top 10
Funds holding in top 10: 14 → 11 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$119M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$108M |
| 3 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$58.8M |
| 4 |
JP Morgan Chase
New York
|
+$54.9M |
| 5 |
BlackRock
New York
|
+$46.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LSCM
Light Street Capital Management
Palo Alto,
California
|
-$63.8M |
| 2 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
-$48.5M |
| 3 |
6CM
683 Capital Management
New York
|
-$37M |
| 4 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
-$27.8M |
| 5 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
-$19.7M |
CDLX Hedge Fund Activity: Q1 2021 in Review
204 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Cardlytics (CDLX) for Q1 2021, worth a combined $3.35B — down 16% from $3.97B a quarter earlier.
Buyers outnumbered sellers: 47 funds opened new CDLX positions and 36 closed out — a net gain of 11 holders — while 68 added to existing stakes and 66 trimmed.
The largest buyer was Vanguard Group, adding an estimated $119M. The largest seller was Light Street Capital Management, exiting entirely with an estimated $63.8M sold.
- 204 institutional investors held Cardlytics (CDLX) as of Q1 2021, up from 195 in Q4 2020.
- Funds reported $3.35B of Cardlytics stock for Q1 2021, down 16% quarter-over-quarter.
- 47 funds opened new Cardlytics positions in Q1 2021 and 36 closed out, a net change of +11 holders.
- The largest Cardlytics buyer in Q1 2021 was Vanguard Group, an estimated $119M added.
- The largest Cardlytics seller in Q1 2021 was Light Street Capital Management, an estimated $63.8M sold.
Based on aggregated 13F filings for Q1 2021.